CD19 and B-cell non-Hodgkin lymphoma: Results demonstrated an increased functional response (degranulation, IFN-γ production, and specific killing) against B cell lymphomas by CD19-CIML NK cells compared with CD19-NK, CD33-NK, and ML NK cells (133).